Oura Inc. (Nasdaq: OURA) sets its public market debut for the week of September 28, 2026, offering 50 million shares priced between $40.00 and $44.00 to target a fully diluted valuation of $15.62 billion. Revenue scaled to $1.21 billion for the nine months ending June 30, 2026 (+74% YoY), driving a net income inflection to $60.8 million alongside expanding recurring SaaS margins.

The migration of red light therapy from clinical exclusivity into the personal sanctuary is being accelerated by a new wave of innovation that transcends the traditional face mask. We are witnessing the democratization of photobiomodulation—once the guarded secret of elite performance labs—now reimagined as a fluid, multi-dimensional lifestyle utility. The Dawn of the "Omnipresent Ritual" For the modern leader, the pursuit of longevity has evolved from a series of appoint